INSIDERFilingvia Quantisnow
Genprex Inc. logo

Genprex (GNPX) executive Confer received 245,000 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Ryan M. Confer (executive at Genprex Inc., GNPX) reported that they received 245,000 shares on Feb 18, 2023. After these transactions the filing shows 435,499 shares held directly.

Reporting person
Confer Ryan M.
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Feb 18, 2023Grant or award (A)Common Stock1+245,000--435,499 direct

Holdings before and after

  • Common Stock: 190,499 to 435,499 direct

Footnotes from the filing

  1. 1. This award of Restricted Stock Units ( RSUs ) is granted under the Genprex, Inc. (the Company ) 2018 Equity Incentive Plan and vests in installments of 50% on the first anniversary of the date of grant and the remaining 50% on the second anniversary of the date of grant. Vested RSUs will be paid in shares of the Company's common stock, $0.001 par value, on a one-to-one basis.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Confer report in this GNPX Form 4?

Ryan M. Confer (executive at Genprex Inc., GNPX) reported that they received 245,000 shares on Feb 18, 2023. After these transactions the filing shows 435,499 shares held directly.

How many GNPX shares does Confer hold after this filing?

The filing shows 435,499 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for GNPX

Earlier insider filings at GNPX

Quantisnow market dataNASDAQ
Genprex Inc. logo
GNPX
Genprex Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2018
Get push alerts for GNPX

Follow GNPX and get a push notification the moment its next story breaks.

Full GNPX profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GNPX (Genprex Inc.) and more on Quantisnow.